Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis

• Renee N Donahue,
• Jeffrey Schlom,
• James L Gulley,
• Christian S Hinrichs,
• Jay Friedman,
• Houssein Abdul Sater,
• Yvette Robbins,
• Cem Sievers,
• Paul E Clavijo,
• Clint Allen,
• Ke Bai,
• Andrew Sinkoe,
• Scott Norberg

Affiliations

Renee N Donahue

Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA

Jeffrey Schlom

Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA

James L Gulley

Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA

Christian S Hinrichs

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA

Jay Friedman

Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA

Houssein Abdul Sater

Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA

Yvette Robbins

Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA

Cem Sievers

Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA

Paul E Clavijo

Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA

Clint Allen

Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA

Ke Bai

Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA

Andrew Sinkoe

Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA

Scott Norberg

Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA